Role of diacylglycerol induced by hypoxia in the regulation of HIF-1α activity

Biochemical and Biophysical Research Communications

Volumn 315, Issue 1, 2004, Pages 44-50

  Temes, Elisa ^a   Martín Puig, Silvia ^a   Aragonés, Julián ^a,c   Jones, David R ^b,d   Olmos, Gemma ^a   Mérida, Isabel ^b   Landázuri, Manuel O ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Diacylglycerol; HIF 1; Hypoxia; Lipid second messengers; Phosphatidic acid; Protein regulation; Signal transduction

Indexed keywords

DIACYLGLYCEROL; DIACYLGLYCEROL KINASE; HYPOXIA INDUCIBLE FACTOR 1; ISOPROTEIN; PHOSPHATIDIC ACID; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; SPHINGOMYELIN; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ARTICLE; BIOACCUMULATION; CELL TYPE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; HYPOXIA; INTRACELLULAR SPACE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0842308118     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.015     Document Type: Article

References (38)

1. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:2003;677-684.
2. Wenger R.H. Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 203:2000;1253-1263.
3. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1995;1230-1237.
4. Kaelin W.G.J. Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer. 2:2002;673-682.
5. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis (see comments). Nature. 399:1999;271-275.
6. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292:2001;468-472.
7. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Kaelin W.G. Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 292:2001;464-468.
8. Huang L.E., Arany Z., Livingston D.M., Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271:1996;32253-32259.
9. Berra E., Benizri E., Ginouves A., Volmat V., Roux D., Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 22:2003;4082-4090.
10. Del Peso L., Castellanos M.C., Temes E., Martin-Puig S., Cuevas Y., Olmos G., Landazuri M.O. The von Hippel-Lindau/hypoxia inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 12:2003;123-128.
11. Aragones J., Jones D.R., Martin S., San Juan M.A., Alfranca A., Vidal F., Vara A., Merida I., Landazuri M.O. Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor 1 by low oxygen tension. J. Biol. Chem. 276:2001;10548-10555.
12. Katan M. Families of phosphoinositide-specific phospholipase C: structure and function. Biochim. Biophys. Acta. 1436:1998;5-17.
13. Singer W.D., Brown H.A., Sternweis P.C. Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D. Annu. Rev. Biochem. 66:1997;475-509.
14. Kozawa O., Suzuki A., Kaida T., Tokuda H., Uematsu T. Tumor necrosis factor-alpha autoregulates interleukin-6 synthesis via activation of protein kinase C. Function of sphingosine 1-phosphate and phosphatidylcholine-specific phospholipase C. J. Biol. Chem. 272:1997;25099-25104.
15. Zamorano J., Rivas M.D., Garcia-Trinidad A., Qu C.K., Keegan A.D. Phosphatidylcholine-specific phospholipase C activity is necessary for the activation of STAT6. J. Immunol. 171:2003;4203-4209.
16. Schutze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., Kronke M. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell. 71:1992;765-776.
17. Preuss I., Kaiser I., Gehring U. Molecular characterization of a phosphatidylcholine-hydrolyzing phospholipase C. Eur. J. Biochem. 268:2001;5081-5091.
18. Ito H., Adachi S., Tamamori M., Fujisaki H., Tanaka M., Lin M., Akimoto H., Marumo F., Hiroe M. Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism. J. Mol. Cell. Cardiol. 28:1996;1271-1277.
19. Luberto C., Hannun Y.A. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine- specific phospholipase C? J. Biol. Chem. 273:1998;14550-14559.
20. Shirai Y., Saito N. Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J. Biochem. 132:2002;663-668.
21. Michell R.H. The multiplying roles of inositol lipids and phosphates in cell control processes. Essays Biochem. 32:1997;31-47.
22. Bligh E., Dyer W. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
23. Flores I., Martinez A.C., Hannun Y.A., Merida I. Dual role of ceramide in the control of apoptosis following IL-2 withdrawal. J. Immunol. 160:1998;3528-3533.
24. Bartlett G. Phosphorous assay in column chromatography. J. Biol. Chem. 234:1958;466-468.
25. Nueda A., Lopez-Cabrera M., Vara A., Corbi A.L. Characterization of the CD11a (alpha L, LFA-1 alpha) integrin gene promoter. J. Biol. Chem. 268:1993;19305-19311.
26. Sambrook J., Fritsch E., Maniatis T. Molecular cloning. A Laboratory Manual. second ed. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Goldberg M., Zhang H.L., Steinberg S.F. Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J. Clin. Invest. 99:1997;55-61.
28. Yoshioka K., Clejan S., Fisher J.W. Activation of protein kinase C in human hepatocellular carcinoma (HEP3B) cells increases erythropoietin production. Life Sci. 63:1998;523-535.
29. Ito J., Nagayasu Y., Ueno S., Yokoyama S. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner. J. Biol. Chem. 277:2002;44709-44714.
30. Smith R.J., Sam L.M., Justen J.M., Bundy G.L., Bala G.A., Bleasdale J.E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmacol. Exp. Ther. 253:1990;688-697.
31. 2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J. Physiol. 517:1999;121-134.
32. Broad L.M., Braun F.J., Lievremont J.P., Bird G.S., Kurosaki T., Putney J.W.J. Role of the phospholipase C-inositol 1,4,5-trisphosphate pathway in calcium release-activated calcium current and capacitative calcium entry. J. Biol. Chem. 276:2001;15945-15952.
33. Yeo E.J., Exton J.H. Stimulation of phospholipase D by epidermal growth factor requires protein kinase C activation in Swiss 3T3 cells. J. Biol. Chem. 270:1995;3980-3988.
34. Gashler A., Sukhatme V.P. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic. Acid Res. Mol. Biol. 50:1995;191-224.
35. Andrew A.S., Klei L.R., Barchowsky A. Nickel requires hypoxia-inducible factor-1a, not redox signaling, to induce plasminogen activator inhibitor-1. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L607-L615.
36. Gysembergh A., Zakaroff-Girard A., Loufoua J., Meunier L., Andre-Fouet X., Lagarde M., Prigent A.F., Ovize M. Brief preconditioning ischemia alters diacylglycerol content and composition in rabbit heart. Basic Res. Cardiol. 95:2000;457-465.
37. Yan S.F., Lu J., Zou Y.S., Kisiel W., Mackman N., Leitges M., Steinberg S., Pinsky D., Stern D. Protein kinase C-beta and oxygen deprivation. A novel Egr-1-dependent pathway for fibrin deposition in hypoxemic vasculature. J. Biol. Chem. 275:2000;11921-11928.
38. Page E.L., Robitaille G.A., Pouyssegur J., Richard D.E. Induction of hypoxia-inducible factor 1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 277:2002;48403-48409.